NL8104297A - Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan. - Google Patents

Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan. Download PDF

Info

Publication number: NL8104297A
Authority: NL; Netherlands
Prior art keywords: fmdv; nucleotide sequence; molecule according; code; protein
Prior art date: 1980-09-18

Application number

NL8104297A

Other languages

English (en)

Dutch (nl)

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-09-18

Filing date

1981-09-17

Publication date

1982-04-16

1981-09-17 Application filed by Wellcome Found filed Critical Wellcome Found

1982-04-16 Publication of NL8104297A publication Critical patent/NL8104297A/nl

Links

238000000034 method Methods 0.000 title claims description 44
241000700605 Viruses Species 0.000 title claims description 24
238000002360 preparation method Methods 0.000 title claims description 9
102000040430 polynucleotide Human genes 0.000 title 1
108091033319 polynucleotide Proteins 0.000 title 1
239000002157 polynucleotide Substances 0.000 title 1
108090000623 proteins and genes Proteins 0.000 claims description 77
241000710198 Foot-and-mouth disease virus Species 0.000 claims description 74
239000002773 nucleotide Substances 0.000 claims description 60
125000003729 nucleotide group Chemical group 0.000 claims description 60
102000004169 proteins and genes Human genes 0.000 claims description 59
238000010367 cloning Methods 0.000 claims description 42
230000015556 catabolic process Effects 0.000 claims description 15
238000006731 degradation reaction Methods 0.000 claims description 15
239000012634 fragment Substances 0.000 claims description 15
108091034117 Oligonucleotide Proteins 0.000 claims description 14
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
108091008146 restriction endonucleases Proteins 0.000 claims description 12
241001465754 Metazoa Species 0.000 claims description 9
239000003999 initiator Substances 0.000 claims description 8
238000013507 mapping Methods 0.000 claims description 8
229960005486 vaccine Drugs 0.000 claims description 8
108090000565 Capsid Proteins Proteins 0.000 claims description 7
102100023321 Ceruloplasmin Human genes 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 7
239000002243 precursor Substances 0.000 claims description 7
108700007698 Genetic Terminator Regions Proteins 0.000 claims description 6
230000004936 stimulating effect Effects 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 5
230000005847 immunogenicity Effects 0.000 claims description 5
101710118046 RNA-directed RNA polymerase Proteins 0.000 claims description 3
KZENBFUSKMWCJF-UHFFFAOYSA-N [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol Chemical compound S1C(CO)=CC=C1C1=CC=C(C=2SC(CO)=CC=2)O1 KZENBFUSKMWCJF-UHFFFAOYSA-N 0.000 claims description 2
239000000427 antigen Substances 0.000 claims description 2
108091007433 antigens Proteins 0.000 claims description 2
102000036639 antigens Human genes 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
239000000835 fiber Substances 0.000 claims 10
241000219793 Trifolium Species 0.000 claims 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
239000013612 plasmid Substances 0.000 description 42
108090000765 processed proteins & peptides Proteins 0.000 description 41
229920001184 polypeptide Polymers 0.000 description 40
102000004196 processed proteins & peptides Human genes 0.000 description 40
239000002299 complementary DNA Substances 0.000 description 27
108020004414 DNA Proteins 0.000 description 25
108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
241000274553 Eggplant mottled dwarf nucleorhabdovirus Species 0.000 description 19
239000000047 product Substances 0.000 description 18
210000004027 cell Anatomy 0.000 description 17
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
230000015572 biosynthetic process Effects 0.000 description 14
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
239000000872 buffer Substances 0.000 description 13
238000010586 diagram Methods 0.000 description 13
239000008188 pellet Substances 0.000 description 12
230000014616 translation Effects 0.000 description 12
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 11
238000013519 translation Methods 0.000 description 11
241000588724 Escherichia coli Species 0.000 description 10
238000003786 synthesis reaction Methods 0.000 description 9
241000894006 Bacteria Species 0.000 description 8
108020004511 Recombinant DNA Proteins 0.000 description 8
230000001580 bacterial effect Effects 0.000 description 8
238000011160 research Methods 0.000 description 8
239000011780 sodium chloride Substances 0.000 description 8
102000053602 DNA Human genes 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
125000003275 alpha amino acid group Chemical group 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 6
101710163270 Nuclease Proteins 0.000 description 6
108091028043 Nucleic acid sequence Proteins 0.000 description 6
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
150000001413 amino acids Chemical class 0.000 description 6
210000004899 c-terminal region Anatomy 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
239000007788 liquid Substances 0.000 description 6
239000000203 mixture Substances 0.000 description 6
239000000243 solution Substances 0.000 description 6
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 5
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 5
239000011543 agarose gel Substances 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
238000010276 construction Methods 0.000 description 5
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 5
230000004927 fusion Effects 0.000 description 5
239000000499 gel Substances 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
108010042407 Endonucleases Proteins 0.000 description 4
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
239000004098 Tetracycline Substances 0.000 description 4
239000002253 acid Substances 0.000 description 4
229960000723 ampicillin Drugs 0.000 description 4
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
239000007857 degradation product Substances 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
229920001519 homopolymer Polymers 0.000 description 4
238000011534 incubation Methods 0.000 description 4
239000010410 layer Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
230000008569 process Effects 0.000 description 4
239000001632 sodium acetate Substances 0.000 description 4
235000017281 sodium acetate Nutrition 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
229960002180 tetracycline Drugs 0.000 description 4
229930101283 tetracycline Natural products 0.000 description 4
235000019364 tetracycline Nutrition 0.000 description 4
150000003522 tetracyclines Chemical class 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
229920001817 Agar Polymers 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
102100031780 Endonuclease Human genes 0.000 description 3
241001131785 Escherichia coli HB101 Species 0.000 description 3
102000003960 Ligases Human genes 0.000 description 3
108090000364 Ligases Proteins 0.000 description 3
108010083644 Ribonucleases Proteins 0.000 description 3
102000006382 Ribonucleases Human genes 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
101710172711 Structural protein Proteins 0.000 description 3
239000008272 agar Substances 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
239000013613 expression plasmid Substances 0.000 description 3
239000007789 gas Substances 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
231100000252 nontoxic Toxicity 0.000 description 3
230000003000 nontoxic effect Effects 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000012360 testing method Methods 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
240000005369 Alstonia scholaris Species 0.000 description 2
108010077805 Bacterial Proteins Proteins 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
108090000204 Dipeptidase 1 Proteins 0.000 description 2
108060002716 Exonuclease Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
108010087702 Penicillinase Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
238000003491 array Methods 0.000 description 2
102000006635 beta-lactamase Human genes 0.000 description 2
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000001816 cooling Methods 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000012869 ethanol precipitation Methods 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
102000013165 exonuclease Human genes 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
238000009629 microbiological culture Methods 0.000 description 2
208000030194 mouth disease Diseases 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000002972 pentoses Chemical class 0.000 description 2
239000012071 phase Substances 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
238000011084 recovery Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
241000894007 species Species 0.000 description 2
238000009987 spinning Methods 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
230000009466 transformation Effects 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
239000013598 vector Substances 0.000 description 2
LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
GFGSZUNNBQXGMK-UHFFFAOYSA-N 2-chloro-4-nitrobenzamide Chemical compound NC(=O)C1=CC=C([N+]([O-])=O)C=C1Cl GFGSZUNNBQXGMK-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
101100176927 Bacillus subtilis (strain 168) bglS gene Proteins 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
101710197665 Capsid protein VP2 Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
101000946191 Galerina sp Laccase-1 Proteins 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
101000740205 Homo sapiens Sal-like protein 1 Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 1
108010031099 Mannose Receptor Proteins 0.000 description 1
101100381589 Mus musculus Glb1 gene Proteins 0.000 description 1
101100236068 Mus musculus Lrba gene Proteins 0.000 description 1
PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108010076039 Polyproteins Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
108010034634 Repressor Proteins Proteins 0.000 description 1
102000009661 Repressor Proteins Human genes 0.000 description 1
108010046983 Ribonuclease T1 Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
102100037204 Sal-like protein 1 Human genes 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
101710140501 Sulfate adenylyltransferase subunit 2 1 Proteins 0.000 description 1
101710173681 Sulfate adenylyltransferase subunit 2 2 Proteins 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
238000003916 acid precipitation Methods 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000013553 cell monolayer Substances 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000000287 crude extract Substances 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
LTFMZDNNPPEQNG-UHFFFAOYSA-N deoxyguanylic acid Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(COP(O)(O)=O)O1 LTFMZDNNPPEQNG-UHFFFAOYSA-N 0.000 description 1
238000009795 derivation Methods 0.000 description 1
GSGDEXIVECIUGP-UHFFFAOYSA-N dimethylarsinic acid;hydrochloride Chemical compound Cl.C[As](C)(O)=O GSGDEXIVECIUGP-UHFFFAOYSA-N 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000012154 double-distilled water Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000005868 electrolysis reaction Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000000763 evoking effect Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
229920006158 high molecular weight polymer Polymers 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000008676 import Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
244000144972 livestock Species 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229940031348 multivalent vaccine Drugs 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000013049 sediment Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NL8104297A 1980-09-18 1981-09-17 Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan. NL8104297A (nl)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
GB8030208		1980-09-18
GB8030208		1980-09-18
GB8034130		1980-10-22
GB8034130		1980-10-22
GB8038147		1980-11-27
GB8038147		1980-11-27
GB8111064		1981-04-08
GB8111064		1981-04-08
GB8125150		1981-08-18
GB8125150		1981-08-18

Publications (1)

Publication Number	Publication Date
NL8104297A true NL8104297A (nl)	1982-04-16

Family

ID=27516415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8104297A NL8104297A (nl)	1980-09-18	1981-09-17	Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan.

Country Status (13)

Country	Link
EP (1)	EP0048455A3 (sv)
AT (1)	AT383612B (sv)
AU (1)	AU555072B2 (sv)
DE (1)	DE3137300A1 (sv)
DK (1)	DK413681A (sv)
FR (1)	FR2490239A1 (sv)
GB (1)	GB2084583B (sv)
IE (1)	IE51586B1 (sv)
IT (1)	IT1210576B (sv)
NL (1)	NL8104297A (sv)
NZ (1)	NZ198388A (sv)
PH (1)	PH21371A (sv)
SE (1)	SE8105516L (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4719177A (en) *	1981-04-20	1988-01-12	Massachusetts Institute Of Technology	Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
GB2103622B (en) *	1981-06-16	1986-01-15	Genentech Inc	Production of foot and mouth disease vaccine from microbially expressed antigens
CA1338705C (en) *	1981-10-22	1996-11-12	Roy Curtiss Iii	Vaccines obtained from antigenic gene products of recombinant genes
ZA831854B (en) *	1982-03-26	1984-01-25	Biogen Nv	Small peptides with the specificity of foot and mouth disease viral antigens
US4751083A (en) *	1982-05-06	1988-06-14	Massachusetts Institute Of Technology	Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US5230888A (en) *	1982-05-06	1993-07-27	Massachusetts Institute Of Technology	Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (en) *	1982-09-30	1984-04-18	The Wellcome Foundation Limited	Novel antigens and vaccines containing them
WO1984003506A1 (en) *	1983-03-08	1984-09-13	Commw Serum Lab Commission	Antigenically active amino acid sequences
JPS59219235A (ja) *	1983-05-30	1984-12-10	Mitsui Toatsu Chem Inc	消化性潰瘍用剤
AU3078295A (en)	1994-07-22	1996-02-22	Boehringer Ingelheim Vetmedica Gmbh	Picornavirus l proteinase and methods of making and using thereof
GB201014965D0 (en)	2010-09-08	2010-10-20	Animal Health Inst	Vaccine
CN114921397A (zh) *	2022-06-02	2022-08-19	中国农业科学院兰州兽医研究所	表达sat2型口蹄疫病毒结构蛋白vp3的枯草芽孢杆菌及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4140763A (en) *	1976-09-08	1979-02-20	The United States Of America As Represented By The Secretary Of Agriculture	Vaccine for foot and mouth disease
BR8102922A (pt) *	1980-05-12	1982-02-02	Biogen Nv	Sequencia de dna, variante de sequencia, molecula de dna recombinante, hospedeiro transformado, polipeptidio ou fragmento ou derivado transformar um hospedeiro, produzir um polipeptidio ou selecionar uma sequencia de dna, bem como composicao e processo para tratar animais fissipedes
GB2103622B (en) *	1981-06-16	1986-01-15	Genentech Inc	Production of foot and mouth disease vaccine from microbially expressed antigens

1981
- 1981-09-17 AT AT0402481A patent/AT383612B/de not_active IP Right Cessation
- 1981-09-17 EP EP81107367A patent/EP0048455A3/en not_active Withdrawn
- 1981-09-17 DK DK413681A patent/DK413681A/da not_active Application Discontinuation
- 1981-09-17 SE SE8105516A patent/SE8105516L/sv not_active Application Discontinuation
- 1981-09-17 AU AU75418/81A patent/AU555072B2/en not_active Ceased
- 1981-09-17 PH PH26213A patent/PH21371A/en unknown
- 1981-09-17 GB GB8128106A patent/GB2084583B/en not_active Expired
- 1981-09-17 FR FR8117565A patent/FR2490239A1/fr active Pending
- 1981-09-17 NL NL8104297A patent/NL8104297A/nl not_active Application Discontinuation
- 1981-09-17 IE IE2164/81A patent/IE51586B1/en unknown
- 1981-09-17 IT IT8149316A patent/IT1210576B/it active
- 1981-09-17 NZ NZ198388A patent/NZ198388A/en unknown
- 1981-09-18 DE DE19813137300 patent/DE3137300A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
EP0048455A2 (en)	1982-03-31
AU7541881A (en)	1982-03-25
IT8149316A0 (it)	1981-09-17
PH21371A (en)	1987-10-15
FR2490239A1 (fr)	1982-03-19
IE51586B1 (en)	1987-01-21
AU555072B2 (en)	1986-09-11
NZ198388A (en)	1985-05-31
SE8105516L (sv)	1982-03-19
DK413681A (da)	1982-03-19
AT383612B (de)	1987-07-27
ATA402481A (de)	1986-12-15
IT1210576B (it)	1989-09-14
GB2084583A (en)	1982-04-15
IE812164L (en)	1982-10-08
DE3137300A1 (de)	1982-11-25
GB2084583B (en)	1984-12-19
EP0048455A3 (en)	1982-09-15

Publication	Publication Date	Title
JPS6352883A (ja)	1988-03-07	Ｈｂｖ抗原性を示すポリペプチドをコ−ドするｄｎａ配列
Li et al.	2011	FMD subunit vaccine produced using a silkworm–baculovirus expression system: Protective efficacy against two type Asia1 isolates in cattle
NL8104297A (nl)	1982-04-16	Dna-moleculen met polynucleotidevolgordes die geheel of ten dele overeenkomen met mond- en klauwzeervirus rna, alsmede werkwijze ter bereiding daarvan.
CN110156896B (zh)	2024-03-22	重组口蹄疫病毒样颗粒及其制备方法和应用
CN104404074A (zh)	2015-03-11	口蹄疫病毒衣壳蛋白串联共表达和病毒样颗粒的制备方法
Balamurugan et al.	2003	Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type ‘O’produced in Pichia pastoris
CN117143924B (zh)	2024-03-22	共表达猫杯状病毒和猫细小病毒抗原蛋白的重组猫疱疹病毒及其活载体疫苗和应用
US4738846A (en)	1988-04-19	Vaccine for vesicular stomatitis virus
US4743554A (en)	1988-05-10	Recombinant DNA expression vector encoding for foot and mouth disease virus proteins
CN116102660B (zh)	2023-11-21	一种猪细小病毒基因工程表位疫苗及其制备方法
CN112430625B (zh)	2022-08-05	含有变异猪伪狂犬病病毒gD蛋白基因的重组腺相关病毒转移载体、病毒及其制备和应用
FR2521165A1 (fr)	1983-08-12	Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
JP3529134B2 (ja)	2004-05-24	組換えネコヘルペスウイルスのベクターワクチン
JPH05501950A (ja)	1993-04-15	変異株仮性狂犬病ウィルス及びそれを含有するワクチン
CN108410784B (zh)	2021-07-27	猪链球菌△CPS/SsnA-mSly(P353L)-SC19工程菌及在疫苗中应用
CN106916832B (zh)	2021-01-05	O型口蹄疫病毒重组核酸、重组疫苗株及其制备方法和应用
CN116218889A (zh)	2023-06-06	一种表达猫细小病毒VP2蛋白的mRNA疫苗及其制备方法
DE60028365T2 (de)	2007-04-12	Chimäre nukleinsäuren und polypeptide aus lyssavirus
KR940005590B1 (ko)	1994-06-21	두창비루스의 a-형 봉입체용 유전자
BE890393A (fr)	1982-03-17	Acide desoxyribonucleique synthetique et procede pour l'obtenir
CN113388585B (zh)	2024-05-14	一种噬菌体高滴度培养方法与应用
US11191824B1 (en)	2021-12-07	Method of purifying virus-like-particles
CN103656682B (zh)	2017-04-12	抗o型口蹄疫多肽‑核酸双效类病毒颗粒疫苗及制备方法
CN115820679A (zh)	2023-03-21	一种抗猪流行性腹泻病毒的环状rna疫苗及其构建方法与应用
KR0142210B1 (ko)	1998-07-01	돼지파보바이러스 vp2 단백질의 대량 생산방법 및 돼지파보바이러스 감염증용 백신용 백신의 제조방법

Legal Events

Date	Code	Title
1982-08-02	BT	A notification was added to the application dossier and made available to the public
1985-01-01	A85	Still pending on 85-01-01
1986-05-01	BV	The patent application has lapsed